Leukemia study finds mutation that limits blood stem cells

06/5/2013 | Genetic Engineering & Biotechnology News

Researchers have discovered that a single mutation in the leukemia-associated gene JAK2 can reduce the ability of blood stem cells to replicate. The mutation is commonly present in patients with myeloproliferative neoplasms. The team plans to further study the effect of additional mutations on cells, which could provide clues on how leukemia develops. The findings were reported in PLOS Biology.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park